Replies to post #597307 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

I agree hank. Has Bosch ever had a talk about all solid tumors?

No!

Management are telling us GBM in the bag whereas SEC filings state many times they want to launch more trials.

I believe the 3M payment will be one of many to secure partnership.

[FeMike]

here has been very little discussion of the likely contents of MB's upcoming ASCO talk on June 3 and how, if at all, it will affect share price and will (or will not) have new info of significance.

Very likely will be filed under the "just another ASCO" category when all is said and done.

I do think MB will have some very interesting combo information to share, and that will be worth paying attention to from a long term/science vantage. Nothing that will impact NWBO share price, though.

I think the biggest wild card is if something slips (intentionally or otherwise) about a timeline or milestone. i.e. MB says "we're hoping to have the application submitted very soon" or "once this expansion (at Sawston) is done we can submit for marketing approval;" something to that effect. Doubt it, but worth tuning into just in case.